Abstract:BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a common heritable myocardiopathy. Although HCM has been reported to be associated with many variants of genes involved in sarcomeric protein biomechanics, pathogenic genes have not been identified in patients with partial HCM. FARS2 (the mitochondrial phenylalanyl-tRNA synthetase), a type of mitochondrial aminoacyl-tRNA synthetase, plays a role in the mitochondrial translation machinery. Several variants of FARS2 have been suggested to cause neurological disorders; however, FARS2-associated diseases involving other organs have not been reported. We identified FARS2 as a potential novel pathogenic gene in cardiomyopathy and investigated its effects on mitochondrial homeostasis and the myocardiopathy phenotype. METHODS: FARS2 variants in patients with HCM were identified using whole-exome sequencing, Sanger sequencing, molecular docking analyses, and cell model investigation. Fars2 conditional mutant (p.R415L) or knockout mice, fars2 -knockdown zebrafish, and Fars2 -knockdown neonatal rat ventricular myocytes were engineered to construct FARS2 deficiency models both in vivo and in vitro. The effects of FARS2 and its role in mitochondrial homeostasis were subsequently evaluated using RNA sequencing and mitochondrial functional analyses. Myocardial tissues from patients were used for further verification. RESULTS: We identified 7 unreported FARS2 variants in patients with HCM. Heart-specific Fars2 -deficient mice presented cardiac hypertrophy, left ventricular dilation, progressive heart failure accompanied by myocardial and mitochondrial dysfunction, and a short life span. Heterozygous cardiac-specific Fars2 R415L mice displayed a tendency to cardiac hypertrophy at age 4 weeks, accompanied by myocardial dysfunction. In addition, fars2 -knockdown zebrafish presented pericardial edema and heart failure. FARS2 deficiency impaired mitochondrial homeostasis by directly blocking the aminoacylation of mt-tRNA Phe and inhibiting the synthesis of mitochondrial proteins, ultimately contributing to an imbalanced mitochondrial quality control system by accelerating mitochondrial hyperfragmentation and disrupting mitochondrion-related autophagy. Interfering with the mitochondrial quality control system using adeno-associated virus 9 or specific inhibitors mitigated the cardiac and mitochondrial dysfunction triggered by FARS2 deficiency by restoring mitochondrial homeostasis. CONCLUSIONS: Our findings unveil the previously unrecognized role of FARS2 in heart and mitochondrial homeostasis. This study may provide new insights into the molecular diagnosis and prevention of heritable cardiomyopathy as well as therapeutic options for FARS2-associated cardiomyopathy.

A Newly Identified Missense Mutation in FARS2 Causes Autosomal Recessive Spastic Paraplegia.

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

A pseudo‐homozygous missense variant and Alu‐mediated exon 5 deletion in FARS2 causing spastic paraplegia 77

Exon 8-17 Deletions of Spast in A Chinese Family with Hereditary Spastic Paraplegia: A Case Report and Literature Review

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

A Novel SPAST Gene Mutation Identified in a Chinese Family with Hereditary Spastic Paraplegia

Neuropathy-associated Fars2 Deficiency Affects Neuronal Development and Potentiates Neuronal Apoptosis by Impairing Mitochondrial Function

A novel missense mutation in SPAST causes hereditary spastic paraplegia in male members of a family: A case report

FARS2 Deficiency in Drosophila Reveals the Developmental Delay and Seizure Manifested by Aberrant Mitochondrial Trna Metabolism.

FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System

A Missense Mutation in SLC33A1, Which Encodes the Acetyl-Coa Transporter, Causes Autosomal-Dominant Spastic Paraplegia (SPG42).

A rare family with Hereditary Spastic Paraplegia Type 35 due to novel FA2H mutations: a case report with literature review.

Investigation of a Fused in Sarcoma Splicing Mutation in a Chinese Amyotrophic Lateral Sclerosis Patient.

A novel variant (p.A524P) in Spastin is responsible for a Chinese family with hereditary spastic paraplegia

Novel Mutations C.[5121_5122insag]+[6859c>t] of the SPG11 Gene Associated with Cerebellum Hypometabolism in a Chinese Case of Hereditary Spastic Paraplegia with Thin Corpus Callosum.

SPG35 Contributes to the Second Common Subtype of AR‐HSP in China: Frequency Analysis and Functional Characterization of FA2H Gene Mutations

Novel Deletion of SPAST in a Chinese Family with Hereditary Spastic Paraplegia

Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia

Bi‐allelic mutations in HARS1 severely impair histidyl‐tRNA synthetase expression and enzymatic activity causing a novel multisystem ataxic syndrome

Case Report: Hereditary Spastic Paraplegia with a Novel Homozygous Mutation in ZFYVE26